Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071974
Filing Date
2025-05-15
Accepted
2025-05-15 07:16:36
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ivvd-20250331.htm   iXBRL 10-Q 1782558
2 EX-31.1 ivvd-ex31_1.htm EX-31.1 19252
3 EX-32.1 ivvd-ex32_1.htm EX-32.1 11509
  Complete submission text file 0000950170-25-071974.txt   8073162

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250331.xsd EX-101.SCH 1301282
79 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250331_htm.xml XML 1322561
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 25948681
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)